Juglone derivatives as antitubercular agents: A rationale for the activity profile

European Journal of Medicinal Chemistry

Volumn 44, Issue 7, 2009, Pages 2847-2853

  Sharma, Smriti ^a   Sharma, Brij K ^a   Prabhakar, Yenamandra S ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

7 Methyljuglone; Antitubercular activity; Combinatorial protocol in multiple linear regression (CP MLR); MODEL (MOlecular DEscriptor Lab) descriptors; PLS; QSAR study

Indexed keywords

DIOSPYRIN; JUGLONE; RAMENTACEONE; TUBERCULOSTATIC AGENT;

ARTICLE; CYTOTOXICITY; DRUG ACTIVITY; DRUG INHIBITION; DRUG STRUCTURE; IN VITRO STUDY; LINEAR REGRESSION ANALYSIS; MOLECULAR MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; STRUCTURE ACTIVITY RELATION; VERO CELL;

ANIMALS; ANTITUBERCULAR AGENTS; CERCOPITHECUS AETHIOPS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; NAPHTHOQUINONES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; VERO CELLS;

EID: 67349133193     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.12.015     Document Type: Article

References (21)

1. WHO Tuberculosis Fact Sheet (2007).
2. El-Sadr W.M., and Tsiouris S.J. Semin. Respir. Crit. Care Med. 29 (2008) 525-531
3. Khasnobis S., Escuyer V.E., and Chatterjee D. Expert Opin. Ther. Targets 6 (2002) 21-40
4. Lall N., and Meyer J.J.M. J. Ethnopharmacol. 78 (2001) 213-216
5. Lall N., and Meyer J.J.M. J. Ethnopharmacol. 66 (1999) 347-354
6. McGaw L.J., Lall N., Hlokwe T.M., Michel A.L., Meyer J.J., and Eloff J.N. Biol. Pharm. Bull. 31 (2008) 1429-1433
7. Lall N., Meyer J.J.M., Wang Y., Bapela N.B., van Rensburg C.E.J., Fourie P.B., and Franzblau S.G. Pharm. Biol. 43 (2005) 353-357
8. Mahapatra A., Mativandlela S.P.N., Binneman B., Fourie P.B., Hamilton C.J., Meyer J.J.M., van der Kooy F., Houghton P., and Lall N. Bioorg. Med. Chem. 15 (2007) 7638-7646
9. Hyun H.K., Kwack Y.I., Lee Y.D., Park Y.H., Lee B.S., and Chan K.K. Bull. Korean Chem. Soc. 25 (2004) 1801-1806
10. Shagufta, Kumar A., Panda G., and Siddiqi M.I. J. Mol. Model. 13 (2007) 99-109
11. Puratchikody A., and Doble M. Bioorg. Med. Chem. 15 (2007) 1083-1090
12. Gupta M.K., Sagar R., Shaw A.K., and Prabhakar Y.S. Bioorg. Med. Chem. 13 (2005) 343-351
13. Saquib M., Gupta M.K., Sagar R., Prabhakar Y.S., Shaw A.K., Kumar R., Maulik P.R., Gaikwad A.N., Sinha S., Srivastava A.K., Chaturvedi V., Srivastava R., and Srivastava B.S. J. Med. Chem. 50 (2007) 2942-2950
14. Li Z.R., Han L.Y., Xue Y., Yap C.W., Li H., Jiang L., and Chen Y.Z. Biotechnol. Bioeng. 97 (2007) 389-396.
15. Prabhakar Y.S. QSAR Comb. Sci. 22 (2003) 583-595
16. MOE: The Molecular Operating Environment from Chemical Computing Group Inc., 1255 University St., Suite 1600, Montreal, Quebec, Canada H3B 3X3. .
17. Wold S. Technometrics 20 (1978) 397-405
18. Kettaneh N., Berglund A., and Wold S. Comput. Stat. Data Anal. 48 (2005) 69-85
19. Stahle L., and Wold S. Multivariate Data Analysis and Experimental Design. In: Eillis G.P., and West W.B. (Eds). Biomedical Research. Progress in Medicinal Chemistry vol. 25 (1988), Elsevier Science Publishers, B.V.
20. Prabhakar Y.S., Solomon V.R., Rawal R.K., Gupta M.K., and Katti S.B. QSAR Comb. Sci. 23 (2004) 234-244
21. So S.S., and Karplus M. J. Med. Chem. 40 (1997) 4347-4359